North America's Dominance in the Long Read Sequencing Market Driven by Key Players and Government Support
FAQ's
Answer : The global biobanking market size was reached at US$ 69 billion in 2021 and is anticipated to rake US$ 115.4 billion by 2030.
Answer : The global biobanking market is growing at a CAGR of 5.9% from 2022 to 2030.
Answer : The major players in biobanking market are Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Brooks Life Sciences, TTP Labtech, VWR International, LLC., Promega Corporation, Worthington Industries, BD, RUCDR Infinite Biologics, and Modul-Bio.
Answer : The rising investments on the drug discovery and drug development owing to the surging prevalence of chronic diseases such as Alzheimerā€™s and cancer among the global population is driving the growth of the biobanking market.
Answer : Europe was the leading biobanking market in 2021 and will lead in the near future.
Get a Sample of this Report
North America's Dominance in the Long Read Sequencing Market
